Asymmetric dimethylarginine predicts mortality and major adverse cardiovascular events in patients with peripheral arterial disease

被引：0
|
作者：
Shin, David S. [1 ]
Weatherby, Carlton W. [1 ]
Wilson, Andrew M. [1 ]
Cooke, John P. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A315 / A315
页数：1
相关论文
共 50 条
  • [1] Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease
    Mittermayer, Friedrich
    Krzyzanowska, Katarzyna
    Exner, Markus
    Mlekusch, Wolfgang
    Amighi, Jasmin
    Sabeti, Schila
    Minar, Erich
    Mueller, Markus
    Wolzt, Michael
    Schillinger, Martin
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (11) : 2536 - 2540
  • [2] Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease
    Wilson, Andrew M.
    Shin, David S.
    Weatherby, Carlton
    Harada, Randall K.
    Ng, Martin K.
    Nair, Nandini
    Kielstein, Jan
    Cooke, John P.
    [J]. VASCULAR MEDICINE, 2010, 15 (04) : 267 - 274
  • [3] ADMA (ASYMMETRIC DIMETHYLARGININE) PREDICTS ALL-CAUSE MORTALITY AND CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: THE GETABI STUDY
    Anderssohn, M.
    Boeger, R. H.
    Endres, H. G.
    Schwedhelm, E.
    Darius, H.
    Atzler, D.
    Lueneburg, N.
    von Stritzky, B.
    Maas, R.
    Thiem, U.
    Benndorf, R. A.
    Diehm, C.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 52 - 53
  • [4] Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with type 2 diabetes
    Mittermayer, Friedrich
    Krzyzanowska, Katarzyna
    Wolzt, Michael
    Schernthaner, Guntram
    [J]. DIABETES, 2007, 56 : A175 - A175
  • [5] Chronic Kidney Disease Predicts Adverse Major Cardiovascular Events and Adverse Limb Events in Patients With Diabetes and Peripheral Arterial Disease
    Rerkasem, Amaraporn
    Mangklabruks, Ampica
    Buranapin, Supawan
    Sony, Kiran
    Inpankaew, Nimit
    Rerkasem, Rath
    Pongtam, Sasinat
    Phirom, Kochaphan
    Rerkasem, Kitttipan
    [J]. INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2024, 23 (01): : 19 - 26
  • [6] Chronic Kidney Disease is Associated With Increased Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Arterial Disease
    Westin, Gregory G.
    Armstrong, Ehrin J.
    Chen, Debbie C.
    Laird, John R.
    [J]. CIRCULATION, 2014, 130
  • [7] Risk Factor Control and Major Adverse Cardiovascular Events in Patients With Peripheral Arterial Disease
    Parvar, Saman L.
    Nicholls, Stephen J.
    Lincoff, A. M.
    Menon, Venu
    Riesmeyer, Jeffrey S.
    Ruotolo, Giacomo
    Wolski, Kathy
    McErlean, Ellen
    Nissen, Steven E.
    [J]. CIRCULATION, 2017, 136
  • [8] Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography
    Lu, Tse-Min
    Chung, Ming-Yi
    Lin, Ming-Wei
    Hsu, Chiao-Po
    Lin, Shing-Jong
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 153 (02) : 135 - 140
  • [9] Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease
    Boeger, R. H.
    Endres, H. G.
    Schwedhelm, E.
    Darius, H.
    Atzler, D.
    Lueneburg, N.
    von Stritzky, B.
    Maas, R.
    Thiem, U.
    Benndorf, R. A.
    Diehm, C.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2011, 269 (03) : 349 - 361
  • [10] Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes
    Krzyzanowska, Katarzyna
    Mittermayer, Friedrich
    Wolzt, Michael
    Schernthaner, Guntram
    [J]. DIABETES CARE, 2007, 30 (07) : 1834 - 1839
12345